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Introduction / objectives
Many strategies are used to control MRSA in hospitals.
Only a few have been assessed in clinical trials and it is
not obvious how findings should be generalised between
settings. Uncertainty remains about which strategies
represent the most appropriate use of scarce resources.
We assess the cost-effectiveness of alternative MRSA
screening and infection control strategies in England
and Wales and discuss international relevance.
Methods
Models of MRSA transmission in ICUs and general
medical (GM) wards were developed and used to evalu-
ate different screening methods combined with decolo-
nisation or isolation. Strategies were compared in terms
of costs and health benefits (quality adjusted life years,
QALYs). Different prevalences, proportions of high risk
patients and ward sizes were investigated, and probabil-
istic sensitivity analyses (PSA) conducted.
Results
Decolonisation strategies were cost-saving in ICUs at a
5% admission prevalence, with admission and weekly
PCR screening the most cost-effective (£3,929/QALY).
In ICUs, screening and isolation reduced infection rates
by ~10%. With admission prevalence ≤5%, targeting
screening and isolation to high risk patients was opti-
mal. In GM wards decolonisation and isolation strate-
gies, though able to reduce MRSA infection rates up to
~50%, were not cost-effective.
Conclusion
The largest reductions in MRSA infection were achieved
by screening and decolonisation strategies, and were
cost-effective in ICU settings. In comparison, there is
limited potential for screening and control strategies to
be cost-effective in GM wards due to lower infection
and mortality rates.
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